Paratek Pharmaceuticals Inc expected to post a loss of 38  cents a share - Earnings Preview

Paratek Pharmaceuticals

14/05/2021 21:38

* Paratek Pharmaceuticals Inc  PRTK.OQ   PRTK.O  is expected
to show a rise in quarterly revenue when it reports results on
May 17 .
* The Boston, Massachusetts-based company is expected to report 
 a 262.6% increase in revenue to $28.719 million from $7.92
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Paratek Pharmaceuticals
Inc is for a loss of 38 cents per share. For the same quarter
last year, the company reported a loss of 66 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Paratek
Pharmaceuticals Inc is $15​, about 50.2% above​ its last closing
price of $7.47. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -0.12       -0.04      -0.60     Missed  -1,233
                                                        .3
 Sep. 30 2020  -0.61       -0.61      -0.46     Beat    24.6
 Jun. 30 2020  -0.23       -0.06      -0.53     Missed  -748​
 Mar. 31 2020  -0.88       -0.80      -0.66     Beat    17.8
 Dec.          -0.75​      -0.81      -0.81     Met     -0.2​
 31​ 2019​                                              
 Sep. 30 2019  -1.04       -1.05      -1.00     Beat    4.5​
 Jun. 30 2019  -1.16       -1.16      -1.02     Beat    11.9
 Mar. 31 2019  -1.19       -1.19      -1.10     Beat    7.5
 This summary was machine generated May 14 at 20:38 GMT.  All
figures in US dollars unless otherwise stated